
Wednesday, April 30, 2025 12:38:01 PM
Spoken like someone who is paid to discredit any and all positive (factual) comments made about DCVax.
Hmm....facts, okay. Let's look at some 'facts' this "Doctor" Greg has asserted over the last few years.
In September of last year he said that Wall Street had finished analyzing the RP deal and we would see steady value growth moving forward because of it, and would start getting news unrelated to the MAA prior to the MHRA decision. Were those facts?
In August of last year after reading the Q2 financials, he posted some garbage from it and said it meant we were "mighty close". Been almost a year. Were those facts?
He also said in August that as soon as the MTD is rejected, NWBO is going to "explode". Was that a fact?
Another August gem, he said DVax-L will be approved prior to 2025 and 2025 revenue would be 120 million. Facts?
Man he was on a roll in August, said that the 3/7 validation verification meant that the MHRA had found no issues and therefore an RFI and application changes were not necessary, and that meant the 3/7 was the start of the 150 day clock on thereby implying a decision imminently. Woof. Those don't seem like facts.
June of 2024, he says that an institutional investor has bought in, a price backstop is in place, and "things are looking really good for longs in the near future". Down 40% since then. Oops.
May 14th 2024 he posted a sketch he scribbled which lead him to the conclusion that August 21st is the latest possible date for approval. Probably sooner though, he says he was being conservative. Facts?
April 10th 2024 he saw guys "putting up 120K shares to dump the SP every day" because they were "getting more desperate". He uses this to estimate 10-14 days til approval. Facts.
March of 2024, he predicts news that will come in the next 3 months: 1) institutional buying 2) up list to NYSE 3) 2 new trials including Merck partnership 4) MHRA approval 5) Revenue from MHRA approval. Yeh that's definitely not pumping.
Also March of 2024, he states a matter of fact that the huge expenditures associated with Flaskworks have been completed and all that is left is to roll it out quickly.
Okay enough 2024, we gotta move on to get through this guy's awful track record.
July 29 2023, Greg Zivvy states some more facts. That DCVax-L will be submitted to both the UK AND Canada, and they will be fast tracked, which GUARANTEES a 150 day answer, but most likely it will be faster. Facts baby.
Mar 2023, called for a $500 million settlement of the MM lawsuit by mid summer (so July of 2023). Def not pumping.
Also Mar 23, he tells investors worried about the rate things are going to relax. He assures us the MHRA moves at LIGHT SPEED and approval is at hand.
Feb 2023, Zivvy says that shorts are trying to lie to investors and say approvals are far off. The dumb doctor says that's wrong, and once the MAA is submitted we are looking at less than 3 months to UK approval and less than 6 months to FDA approval. It's been 2 years and 3 months since this post. This guy is all about some facts.
Also in Feb 23, Gregory retweets a post (and says he totally agrees) that NWBO is already deep into the BLA submission process and FDA submission is imminent. Says anyone who believes the FDA and NWBO haven't already been working together for submission is naive. Facts.
December of 2022, he posts his proof that NICE has officially started its assessment of DCVax-L. Facts.
Sept of 2022, Greg's sense of things: "marketing approval in UK by end of year...canada follows quickly....EMA within 4-6 months....FDA jumps in quick...approval is near in the UK, I predict news in the next 1-3 weeks". Def not pumping.
Sept of 2020, he announces that Linda's ABTA presentation is confirmation that TLD is being unblinded and announced any day.
There are so many more gems but I just can't get through it all.
Anyhow, the list of "facts" that 'Dr.' Greg Zivich has thrown out in the last 5 years on Twitter alone is really something. But yeh, this guy isn't a pumper. No way. Super smart dude. Lots of intelligence. Never wrong.
Recent NWBO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
- Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM